These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 27549768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary.
    Dauvilliers Y, Roth T, Bogan R, Thorpy MJ, Morse AM, Ascencion F, Gudeman J.
    J Comp Eff Res; 2024 Sep; 13(9):e240031. PubMed ID: 39088033
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Narcolepsies, update in 2023.
    Barateau L, Pizza F, Chenini S, Peter-Derex L, Dauvilliers Y.
    Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
    [Abstract] [Full Text] [Related]

  • 7. New developments in the management of narcolepsy.
    Abad VC, Guilleminault C.
    Nat Sci Sleep; 2017 Oct; 9():39-57. PubMed ID: 28424564
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U, Bassetti CL.
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [Abstract] [Full Text] [Related]

  • 9. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
    Thorpy MJ, Bogan RK.
    Sleep Med; 2020 Apr; 68():97-109. PubMed ID: 32032921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
    Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS.
    Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Update on therapy for narcolepsy.
    Thorpy MJ.
    Curr Treat Options Neurol; 2015 May; 17(5):347. PubMed ID: 25854650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.
    Barateau L, Liblau R, Peyron C, Dauvilliers Y.
    CNS Drugs; 2017 Oct; 31(10):821-834. PubMed ID: 28940143
    [Abstract] [Full Text] [Related]

  • 17. Narcolepsy and Other Central Hypersomnias.
    Dauvilliers Y, Barateau L.
    Continuum (Minneap Minn); 2017 Aug; 23(4, Sleep Neurology):989-1004. PubMed ID: 28777172
    [Abstract] [Full Text] [Related]

  • 18. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
    Moresco M, Pizza F, Antelmi E, Plazzi G.
    Curr Drug Metab; 2018 Aug; 19(13):1073-1079. PubMed ID: 29512449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.